Kalamazoo, MI, United States of America

Riqiang Yan

This inventor holds 23 USPTO granted patents, primarily in Alzheimer's Disease Research. Top assignees: Pharmacia & Upjohn Company, Elan Pharmaceuticals, Inc., Other. Active years: 2002-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Riqiang Yan. Retrieved from https://idiyas.com/inventor/riqiang-yan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 47.8

Average Co-Inventor Count = 5.1

ph-index = 12

Forward Citations = 257(Granted Patents)


Location History:

  • Kalamazoo, MI (US) (2002 - 2008)
  • Kalamzoo, MI (US) (2010)
  • Pepper Pike, OH (US) (2010 - 2011)

Company Filing History:


Years Active: 2002-2011

Loading Chart...
Areas of Expertise:
Alzheimer's Disease
Secretase
APP Substrates
Inhibitors
Polynucleotides
Assays
Aspartyl Protease
Biomarkers
Therapeutics
Protease Activity
Diagnostics
Oligonucleotides
23 patents (USPTO):Explore Patents

Title: Inventor Riqiang Yan: A Pioneer in Alzheimer's Research

Introduction

Riqiang Yan, located in Kalamazoo, Michigan, is a notable inventor recognized for his contributions in the field of biomedical research, particularly concerning Alzheimer's disease. With a total of 23 patents to his name, Yan has made significant strides in understanding and treating neurodegenerative disorders.

Latest Patents

Among his latest innovations, Riqiang Yan has developed patented technologies that focus on critical aspects of Alzheimer's disease. One of his noteworthy patents is related to "Substrates and assays for β-secretase." This invention encompasses novel peptide substrates and fusion polypeptide substrates that include a β-secretase cleavage site, along with methods for creating and utilizing these peptides. Another significant patent is titled "Alzheimer's disease secretase," which presents enzymatic processes for cleaving the β-secretase cleavage site of the APP protein. This patent also covers associated nucleic acids, peptides, vectors, cells, cell isolates, and assays, showcasing a comprehensive approach to addressing the complexities of Alzheimer's disease.

Career Highlights

Throughout his career, Riqiang Yan has been affiliated with well-respected organizations such as Pharmacia & Upjohn Company and Elan Pharmaceuticals, Inc. His work in these institutions has allowed him to translate innovative ideas into practical applications, thereby contributing to advancements in therapeutic options for Alzheimer's disease.

Collaborations

Riqiang Yan has collaborated with esteemed colleagues in his field, including Mark E. Gurney and Robert L. Heinrikson. These partnerships have played a crucial role in the successful development of his patents and the push towards more effective treatments for cognitive disorders.

Conclusion

In summary, Riqiang Yan stands out as a pioneering inventor whose work in Alzheimer's research continues to influence the scientific community. His innovative approaches and patents not only demonstrate his expertise but also pave the way for future breakthroughs in neurodegenerative disease treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…